These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 23392394)

  • 1. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
    Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A
    Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
    El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM
    J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials.
    Mirna M; Topf A; Schmutzler L; Hoppe UC; Lichtenauer M
    Clin Res Cardiol; 2022 Oct; 111(10):1077-1086. PubMed ID: 34751788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of ampicillin plus ceftriaxone compared to ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis: a noninferiority question not yet properly investigated.
    Solla DJ
    Clin Infect Dis; 2013 Sep; 57(5):768. PubMed ID: 23704125
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study.
    Ramos-Martínez A; Pericàs JM; Fernández-Cruz A; Muñoz P; Valerio M; Kestler M; Montejo M; Fariñas MC; Sousa D; Domínguez F; Ojeda-Burgos G; Plata A; Vidal L; Miró JM;
    PLoS One; 2020; 15(8):e0237011. PubMed ID: 32745091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
    Freeman L; Milkovits A; McDaniel L; Everson N
    Int J Antimicrob Agents; 2022 Mar; 59(3):106522. PubMed ID: 35038556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.
    Farina C; Russello G; Chinello P; Pasticci MB; Raglio A; Ravasio V; Rizzi M; Scarparo C; Vailati F; Suter F;
    Chemotherapy; 2011; 57(5):426-33. PubMed ID: 22122863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.
    Dahl A; Rasmussen RV; Bundgaard H; Hassager C; Bruun LE; Lauridsen TK; Moser C; Sogaard P; Arpi M; Bruun NE
    Circulation; 2013 Apr; 127(17):1810-7. PubMed ID: 23543002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides?
    Munita JM; Arias CA; Murray BE
    Clin Infect Dis; 2013 May; 56(9):1269-72. PubMed ID: 23392395
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients.
    Pericàs JM; Cervera C; Moreno A; Garcia-de-la-Mària C; Almela M; Falces C; Quintana E; Vidal B; Llopis J; Fuster D; Mestres CA; Marco F; Miró JM;
    PLoS One; 2018; 13(2):e0192387. PubMed ID: 29462176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterococcal endocarditis: a multicenter study of 76 cases].
    Martínez-Marcos FJ; Lomas-Cabezas JM; Hidalgo-Tenorio C; de la Torre-Lima J; Plata-Ciézar A; Reguera-Iglesias JM; Ruiz-Morales J; Márquez-Solero M; Gálvez-Acebal J; de Alarcón-González A;
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):571-9. PubMed ID: 19477041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
    Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
    Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.